ClassID:

20096

A61K9/19 - page 2 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Recent Application in this class:
#301
20250000935
2025-01-02

High-Stability Daptomycin Composition For Injection, And Preparation Method Therefor And Use Thereof

#302
20250000934
2025-01-02

LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND METHOD FOR PREPARATION THEREOF

#303
20250000787
2025-01-02

PROBIOTIC SKIN FORMULATIONS

#304
20240424106
2024-12-26

CONJUGATE PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF

#305
20240424069
2024-12-26

LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS

#306
20240424034
2024-12-26

PAIRING PROBIOTICS AND PREBIOTICS, METHODS FOR GROWTH AND USE, SEPARATELY AND IN COMBINATION

#307
20240424007
2024-12-26

REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES

#308
20240423918
2024-12-26

LYOPHILIZATION SYSTEMS AND METHODS

#309
20240417445
2024-12-19

METHOD FOR PRODUCING A LYOPHILIZED COMPOSITION COMPRISING POLYCLONAL IGM AND COMPOSITION OBTAINED

#310
20240415945
2024-12-19

C1-ESTERASE INHIBITOR PREPARATION

#311
20240415915
2024-12-19

TRADITIONAL CHINESE MEDICINE FERMENTED PREPARATION FOR PREVENTING AND TREATING GOUT, ITS PREPARATION METHOD AND APPLICATION

#312
20240415811
2024-12-19

5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations

#313
20240409552
2024-12-12

GUAIANOLIDE OLIGOMERS, PREPARATION METHOD AND APPLICATION

#314
20240408179
2024-12-12

ORAL DELIVERY OF THERAPEUTIC AGENTS

#315
20240408141
2024-12-12

Methods using freeze-dried platelet derivative compositions for restoring hemostasis in a subject

#316
20240408063
2024-12-12

ENCAPSULATED MICROPARTICLES AND NANOPARTICLES OF DIMETHYLTRIPTAMINES

#317
20240408050
2024-12-12

DIHYDROMYRICETIN SPRAY-DRIED DISPERSION FORMULATIONS AND METHODS FOR FORMING THEM

#318
20240408049
2024-12-12

SOLID DELTA9-TETRAHYDROCANNABINOL (DELTA9-THC) COMPOSITIONS

#319
20240408020
2024-12-12

Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle

#320
20240408019
2024-12-12

METHODS FOR FREEZING AND FREEZE-DRYING LIPID NANOPARTICLES (LNPs) AND LNPs OBTAINED WITH THE SAME

#321
20240408016
2024-12-12

AN INJECTABLE POLYHYDROXYALKANOATE MICROSPHERE AND A PREPARATION METHOD THEREOF

#322
20240400666
2024-12-05

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA

#323
20240398884
2024-12-05

PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF

#324
20240398867
2024-12-05

FECAL MICROBIOTA TRANSPLANT COMPOSITIONS AND METHODS OF MANUFACTURE

#325
20240398841
2024-12-05

BLADDER PERFUSION PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#326
20240398712
2024-12-05

PACKAGE AND METHOD FOR PRODUCING THE SAME

#327
20240393045
2024-11-28

TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT

#328
20240382571
2024-11-21

Albumin-Free Botulinum Toxin Formulations

#329
20240382468
2024-11-21

TETRAZOLE DERIVATIVES

#330
20240382449
2024-11-21

RESINIFERATOXIN COMPOSITIONS

#331
20240376459
2024-11-14

THROMBIN SOLUTION AND METHODS OF USE THEREOF

#332
20240374688
2024-11-14

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

#333
20240374681
2024-11-14

Formulation for Co-Administration of Q-GRFT and Tenofovir

#334
20240374650
2024-11-14

Extracts for the Regeneration of Ligaments

#335
20240368254
2024-11-07

ACCELERATED METHOD OF MAKING LYOPHILIZED PROTEIN FORMUALTIONS

#336
20240366810
2024-11-07

Composition containing a somatostatin analogue for radiopharmaceutical use

#337
20240366730
2024-11-07

Long-Acting Growth Hormone Treatment

#338
20240366673
2024-11-07

METHOD FOR TREATING CELLS

#339
20240366640
2024-11-07

LYOPHILIZED FORMULATION SOLUTION AND LYOPHILIZED FORMULATION, AND METHOD AND USE THEREOF

#340
20240360161
2024-10-31

AMORPHOUS (A-POLYMORPHIC) PSILOCYBIN

#341
20240360101
2024-10-31

PHARMACEUTICAL SALTS OF A CHK-1 INHIBITOR

#342
20240358838
2024-10-31

LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES

#343
20240358800
2024-10-31

FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

#344
20240358647
2024-10-31

Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same

#345
20240350638
2024-10-24

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

#346
20240350467
2024-10-24

[6R]-MTHF IN B6 ENHANCED 5-FU BASED CHEMOTHERAPY OF PANCREATIC CANCER

#347
20240350413
2024-10-24

LYOPHILISED FORMULATIONS OF mRNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES

#348
20240350410
2024-10-24

FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF

#349
20240343815
2024-10-17

PHARMACEUTICAL COMPOSITION OF ANTI-IL4R ANTIBODY AND USE THEREOF

#350
20240342254
2024-10-17

METHOD FOR PRODUCING HUMAN PLASMA-DERIVED FACTOR VIII / VON WILLEBRAND FACTOR AND COMPOSITION OBTAINED

#351
20240342253
2024-10-17

FIBRINOGEN COMPOSITIONS AND METHODS OF PREPARATION

#352
20240342229
2024-10-17

ANTI-FATIGUE LACTOBACILLUS COMPOSITION AND METHOD OF PROMOTING ANTI-FATIGUE PERFORMANCE AFTER AEROBIC EXERCISE OF SUBJECT IN NEED THEREOF BY USING THE SAME

#353
20240342093
2024-10-17

NON-STEROID ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION

#354
20240335482
2024-10-10

BACTERIAL TREATMENT FOR ATOPIC DERMATITIS

#355
20240335387
2024-10-10

Lyophilized Vortioxetine Pamoate Powder for Injection and Preparation Method Therefor

#356
20240327831
2024-10-03

COMPOSITIONS COMPRISING EXON SKIPPING OLIGONUCLEOTIDE CONJUGATES FOR TREATING MUSCULAR DYSTROPHY

#357
20240327465
2024-10-03

PEPTIDES AND ANTIGEN BINDING PROTEINS FOR USE IN IMMUNOTHERAPY AGAINST FIBROLAMELLAR HEPATOCELLULAR CARCINOMA (FL-HCC) AND OTHER CANCERS

#358
20240325596
2024-10-03

MINERAL-COATED SUBSTRATES FOR STABILIZATION OF RNA-BASED THERAPEUTIC COMPOSITIONS

#359
20240325564
2024-10-03

PHARMACEUTICAL COMPOSITION CONTAINING ANTI-TROP2 ANTIBODY DRUG CONJUGATE AND ITS APPLICATION

#360
20240325542
2024-10-03

USE OF A PHOSPHOLIPID AS A CRYSTALLIZATION INHIBITOR

#361
20240325377
2024-10-03

PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORESHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME

#362
20240325332
2024-10-03

Bactericidal and virucidal pharmaceutical composition

#363
20240316204
2024-09-26

COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE

#364
20240316194
2024-09-26

METHOD OF RECONSTITUTING LYOPHILIZED FORMULATION

#365
20240316182
2024-09-26

EXOSOMES COMPRISING CORONAVIRUS-DERIVED ANTIGEN PROTEIN OR GENE ENCODING SAME PROTEIN, AND USE OF SAME

#366
20240316157
2024-09-26

PHARMACEUTICAL COMPOSITION OF PCSK9 INHIBITOR AND GLP-1 RECEPTOR AGONIST

#367
20240316119
2024-09-26

COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS

#368
20240316049
2024-09-26

STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION

#369
20240309073
2024-09-19

METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF

#370
20240307421
2024-09-19

LYOPHILIZED POWDER CONTAINING BORON COMPLEX AND METHOD OF FORMING THE SAME

#371
20240307374
2024-09-19

FORMULATION OF FURIN INHIBITOR FOR INHALATION

#372
20240307368
2024-09-19

ANTIMICROBIAL COMPOSITIONS

#373
20240299509
2024-09-12

NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS

#374
20240299508
2024-09-12

COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES

#375
20240299333
2024-09-12

PHARMACEUTICAL COMPOSITION

#376
20240293479
2024-09-05

PRODUCTION OF A PROBIOTIC COMPOSITION

#377
20240287170
2024-08-29

METHODS FOR TREATING SYSTEMIC SCLEROSIS

#378
20240285766
2024-08-29

Liquid Protein Formulations Containing Ionic Liquids

#379
20240285654
2024-08-29

LOW-SORBING GLYBURIDE FORMULATION AND METHODS

#380
20240285605
2024-08-29

DRIED COSMETIC PREPARATION FOR REHYDRATION AND USE

#381
20240285601
2024-08-29

MALLEABLE CONTROLLED RELEASE LOCAL ANESTHETIC WITH HEMOSTATIC COMPOSITION

#382
20240285536
2024-08-29

FORMULATIONS OF TEGAVIVINT

#383
20240269316
2024-08-15

NUCLEIC ACID SENSOR AGONIST COMPOSITIONS AND USES THEREOF

#384
20240269273
2024-08-15

USE OF AMINO ACIDS AS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS

#385
20240269244
2024-08-15

Pharmaceutical Composition for Treatment of Mucopolysaccharidosis Type 1

#386
20240269229
2024-08-15

NOVEL LIPOPEPTIDE FORMULATION

#387
20240269198
2024-08-15

COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH FUNGI AND OTHER PATHOGENIC MICROBES

#388
20240269077
2024-08-15

SOLUTION FOR PRESERVING EXTRACELLULAR VESICLES/EXOSOMES, METHOD FOR PRESERVING THE SAME, AND MIXED SOLUTION THEREOF

#389
20240269076
2024-08-15

High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients

#390
20240261393
2024-08-08

SARS-CoV-2 RNA vaccine compositions and methods of use

#391
20240261349
2024-08-08

Pharmaceutical Complex for Radioprotection, Preparation Method, and Applications thereof

#392
20240261280
2024-08-08

CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD

#393
20240254248
2024-08-01

CD40 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF

#394
20240254237
2024-08-01

VEDOLIZUMAB FORMULATION

#395
20240252612
2024-08-01

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

#396
20240252604
2024-08-01

NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS

#397
20240252565
2024-08-01

A WATER SOLUBLE OR WATER DISPERSIBLE BOLUS ARTICLE

#398
20240252459
2024-08-01

DILTIAZEM HYDROCHLORIDE AND PREGABALIN COMPOSITION, METHOD FOR PREPARING THE SAME, AND USAGE THEREOF

#399
20240245653
2024-07-25

PHARMACEUTICAL FORMULATIONS

#400
20240245609
2024-07-25

FREEZE-DRIED COMPOSITION CONTAINING ANTI-HER2 DRUG CONJUGATE, FREEZE-DRIED PREPARATION AND PREPARATION METHOD THEREFOR AND USE THEREOF

#401
20240239800
2024-07-18

PYRROLO[2,3-D]PYRIMIDIN-2-ONE ANTIMICROBIAL COMPOUNDS

#402
20240238401
2024-07-18

SOLID COMPOSITION, FREEZE-DRYING METHOD AND GLASS VIAL

#403
20240228606
2024-07-11

USES OF IL-13 ANTAGONISTS FOR TREATING ATOPIC DERMATITIS

#404
20240226187
2024-07-11

Compositions and Methods for Delivering a Bacterial Metabolite to a Subject

#405
20240226105
2024-07-11

TETRODOTOXIN LIQUID FORMULATIONS

#406
20240226028
2024-07-11

LYOPHILIZATION METHODS FOR PREPARING LIPID FORMULATED THERAPEUTICS

#407
20240226015
2024-07-11

COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE MULTI-TARGETED ANTIGENS

#408
20240216498
2024-07-04

LARGE-SCALE FLAVIVIRAL VACCINE PRODUCTION AND MANUFACTURE

#409
20240216495
2024-07-04

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE

#410
20240216366
2024-07-04

PHARMACEUTICAL COMPOSITION COMPRISING A DIPHENYLPYRAZINE DERIVATIVE

#411
20240216281
2024-07-04

MANUFACTURING METHOD OF MEDICATION

#412
20240216274
2024-07-04

Dried nanoparticle compositions

#413
20240208984
2024-06-27

BIVALENT LIGANDS TO UNDERSTAND DIMERIZATION OF THE MU OPIOID RECEPTOR AND THE CHEMOKINE RECEPTOR CCR5 IN NEUROLOGICAL DISORDERS

#414
20240207400
2024-06-27

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

#415
20240207326
2024-06-27

COMPOSITION COMPRISING EGG YOLK AND BURNT CERAL POWDER FOR WOUND HEALING

#416
20240207191
2024-06-27

USE OF MALTODEXTRIN AS AN EXCIPIENT

#417
20240197717
2024-06-20

SUSTAINED-RELEASE INJECTABLE COMPOSITION CONTAINING NALTREXONE AND METHOD FOR PREPARING SAME

#418
20240197638
2024-06-20

Polymer particles for neutrophil injury

#419
20240189288
2024-06-13

TREATMENT OF GLAUCOMA USING ENDOTHELIN RECEPTOR ANTAGONISTS

#420
20240189238
2024-06-13

FRUIT AND/OR VEGETABLE BASED COMPOSITIONS AND METHODS OF PREPARING THE SAME

#421
20240189221
2024-06-13

METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASE

#422
20240181063
2024-06-06

Liquid Protein Formulations Containing Viscosity-Lowering Agents

#423
20240180947
2024-06-06

LYOPHILIZED FORMULATIONS OF CD73 COMPOUNDS

#424
20240180834
2024-06-06

DEVELOPMENT OF COVID-19 VACCINE USING A DUAL TLR LIGAND LIPOSOME ADJUVANT

#425
20240173357
2024-05-30

CARTILAGE EXTRACT WITH EFFECT OF IMPROVING IMMUNE RESPONSE, PREPARATION METHOD THEREFOR, AND USE THEREOF

#426
20240173296
2024-05-30

PHARMACEUTICAL COMPOSITION OF (S)-KETOROLAC AND PREPARATION METHOD THEREFOR

#427
20240165258
2024-05-23

Stable Aqueous Pharmaceutical Composition or Freeze-Dried Pharmaceutical Composition

#428
20240165236
2024-05-23

ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS

#429
20240165222
2024-05-23

VACCINE COMPOSITION FOR PREVENTING SARS-COV-2

#430
20240165205
2024-05-23

INSULIN FORMULATIONS AND METHODS OF USING SAME IN PRETERM INFANTS

#431
20240156914
2024-05-16

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

#432
20240156774
2024-05-16

STABLE DOCETAXEL ALBUMIN NANOPARTICLE COMPOSITION

#433
20240151465
2024-05-09

CONTINUOUS THROUGHPUT LYOPHILIZER-POWDER FILLER WITHIN A STERILE BOUNDARY

#434
20240150467
2024-05-09

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH SUBCUTANEOUS ADMINISTRATION OF ANTI-PD1 ANTIBODIES

#435
20240150463
2024-05-09

IMMUNOTOXINS, FORMULATIONS THEREOF AND THEIR USE IN MEDICINE

#436
20240148852
2024-05-09

VLP stabilized vaccine compositions

#437
20240148815
2024-05-09

FOOD SUPPLEMENT TO PROMOTE BODY WEIGHT LOSS

#438
20240148726
2024-05-09

FREEZE DRIED DRUG NANOSUSPENSIONS

#439
20240148696
2024-05-09

LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION

#440
20240148655
2024-05-09

COMBINATION LYOPHILIZATION AND DISPENSING SYRINGE ASSEMBLY AND METHODS OF USING SAME

#441
20240148654
2024-05-09

LYOPHILIZED AND STABILIZED LIVE ATTENUATED FORMULATED VACCINE AGAINST TULAREMIA

#442
20240141342
2024-05-02

RNA INTERFERENCE DELIVERY FORMULATION AND METHODS FOR MALIGNANT TUMORS

#443
20240139252
2024-05-02

Treatment of von Willebrand disease

#444
20240139236
2024-05-02

COPPER HISTIDINATE COMPOSITIONS AND USES THEREOF

#445
20240139177
2024-05-02

METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION

#446
20240139175
2024-05-02

COMBINATION THERAPY WITH A VINCA ALKALOID N-OXIDE AND AN IMMUNE CHECKPOINT INHIBITOR

#447
20240139137
2024-05-02

Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same

#448
20240139105
2024-05-02

PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6

#449
20240139104
2024-05-02

MICELLE RELEASING THERMOSENSITIVE HYDROGELS AS A THERAPEUTIC DELIVERY SYSTEM

#450
20240131144
2024-04-25

Formulations of dengue virus vaccine compositions

#451
20240131084
2024-04-25

LYOPHILIZED COMPOSITIONS COMPRISING FECAL MICROBE-BASED THERAPEUTIC AGENTS AND METHODS FOR MAKING AND USING SAME

#452
20240131082
2024-04-25

Compositions and Methods for Delivering a Bacterial Metabolite to a Subject

#453
20240131063
2024-04-25

Blood Plasma Product

#454
20240130973
2024-04-25

Compositions, methods and uses for thermally stable multi-targeted antigens

#455
20240123066
2024-04-18

COMPOSITION AND METHODS FOR STABILIZING LIQUID PROTEIN FORMULATIONS

#456
20240122856
2024-04-18

Polylactic acid microsphere, polylactic-co-glycolic acid microsphere and method of preparing the same

#457
20240115760
2024-04-11

LYOPHILIZED POLYMER SCAFFOLD COMPOSITIONS, PROCESSES FOR PREPARATION AND USE IN ANABOLIC WOUND REPAIR

#458
20240115627
2024-04-11

USE OF CLOSTRIDIUM GHONII SPORE COMBINED WITH PEMBROLIZUMAB

#459
20240115503
2024-04-11

INTRAVESICAL DELIVERY OF HYDROPHILIC THERAPEUTIC AGENTS USING LIPOSOMES

#460
20240108701
2024-04-04

FORMULATIONS OF POLYALKYLENE OXIDE-ASPARAGINASE AND METHODS OF MAKING AND USING THE SAME

#461
20240108586
2024-04-04

Nanoparticles Containing a Taxane and their Use

#462
20240108583
2024-04-04

NALTREXONE COMPOSITIONS

#463
20240108580
2024-04-04

DECOQUINATE LIPOSOME, PREPARATION METHOD THEREFOR AND USE THEREOF

#464
20240102071
2024-03-28

Method for preparing active protein peptide and prepared active protein peptide and use thereof

#465
20240101698
2024-03-28

FORMULATIONS OF ANTI-CD73 ANTIBODIES

#466
20240100158
2024-03-28

FREEZE DRIED ANTIBODY FORMULATIONS AND METHODS THEREOF

#467
20240091373
2024-03-21

ANTIBODY-DRUG CONJUGATE LYOPHILISED FORMULATION

#468
20240091369
2024-03-21

BOTULINUM TOXIN FREEZE-DRIED FORMULATION DOSAGE FORM STORABLE FOR LONG TIME

#469
20240091333
2024-03-21

Temperature Stable Nucleic Acid Method for Preparing Vaccines

#470
20240091278
2024-03-21

PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES

#471
20240091251
2024-03-21

COMPOSITIONS COMPRISING AN RNA POLYMERASE INHIBITOR AND CYCLODEXTRIN FOR TREATING VIRAL INFECTIONS

#472
20240091223
2024-03-21

PHARMACEUTICAL COMPOSITION COMPRISING A DIPHENYLPYRAZINE DERIVATIVE

#473
20240091192
2024-03-21

DILUTABLE FORMULATIONS OF CANNABINOIDS AND PROCESSES FOR THEIR PREPARATION

#474
20240084016
2024-03-14

STABLE FORMULATION OF INTEGRIN ANTIBODY

#475
20240083969
2024-03-14

IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS

#476
20240082405
2024-03-14

Low Molecular Weight Silk Compositions and Stabilizing Silk Compositions

#477
20240082322
2024-03-14

COMPOSITION COMPRISING LACTOBACILLUS PLANTARUM FOR PREVENTING AND/OR TREATING MENTAL ILLNESS

#478
20240082167
2024-03-14

SYNTHETIC ARTIFICIAL STEM CELLS (SASC)

#479
20240082161
2024-03-14

STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION

#480
20240075123
2024-03-07

TREATMENT OF CANCERS AND INFECTIOUS DISEASES WITH KILLED INTACT BACTERIA

#481
20240075095
2024-03-07

Daptomycin formulations

#482
20240074977
2024-03-07

Lyophilized formulations of tegavivint

#483
20240066124
2024-02-29

Lyophilized powder configured for reconstitution as a liquid pharmaceutical formulation with reduced viscosity and method of preparing thereof

#484
20240066114
2024-02-29

MULTIVALENT NUCLEIC ACID BASED CORONAVIRUS VACCINES

#485
20240066104
2024-02-29

FORMULATIONS COMPRISING RECOMBINANT ACID ALPHA-GLUCOSIDASE

#486
20240066065
2024-02-29

PLATELET DERIVATIVES FOR TREATING COAGULOPATHY

#487
20240065984
2024-02-29

NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT

#488
20240058332
2024-02-22

CRAC CHANNEL INHIBITOR COMPOSITIONS

#489
20240058296
2024-02-22

MODIFIED ANTIBODY-ALBUMIN NANOPARTICLE COMPLEXES FOR CANCER TREATMENT

#490
20240058272
2024-02-22

STABLE PARENTERAL FORMULATIONS OF DULOXETINE

#491
20240058263
2024-02-22

FORMULATIONS OF ANTIBODY

#492
20240050598
2024-02-15

PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

#493
20240050489
2024-02-15

Compositions and methods for treatment

#494
20240050453
2024-02-15

WATER-SOLUBLE CANNABINOID FORMULATION AND PREPARATION METHOD THEREFOR

#495
20240050421
2024-02-15

PHARMACEUTICAL FORMULATIONS OF A PHENOLIC TRPV1 AGONIST PRODRUG

#496
20240050381
2024-02-15

COMPLEXES COMPRISING COLLAGEN PEPTIDES AND CURCUMINOIDS AND COMPOSITIONS THEREOF

#497
20240043517
2024-02-08

ANTI-GDF15 ANTIBODY AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER

#498
20240043472
2024-02-08

POLYMORPHIC FORMS OF CYCLO (-HIS-PRO) AND METHODS OF USE TO TREAT KIDNEY DISEASE

#499
20240041909
2024-02-08

Preparation of preliposomal annamycin lyophilizate

#500
20240041774
2024-02-08

FREEZE-DRIED ARIPIPRAZOLE FORMULATION

#501
20240041770
2024-02-08

MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES

#502
20240041765
2024-02-08

ORAL LIQUID SUSPENSION OF PAN-RAF KINASE INHIBITOR

#503
20240033344
2024-02-01

PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME

#504
20240033296
2024-02-01

THERAPEUTIC AGENT FOR NERVE DISORDERS

#505
20240033294
2024-02-01

Fecal microbiota transplant compositions and methods of manufacture

#506
20240033223
2024-02-01

FOSPHENYTOIN SODIUM SOLID COMPOSITION, LYOPHILIZATION METHOD, AND USE OF FOSPHENYTOIN SODIUM SOLID COMPOSITION

#507
20240033217
2024-02-01

METHOD OF ORALLY ADMINISTERING A FECAL MICROBIOTA TRANSPLANT COMPOSITION

#508
20240024498
2024-01-25

PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE, AND USE OF PHARMACEUTICAL COMPOSITION

#509
20240024465
2024-01-25

ALLERGEN PREPARATION

#510
20240024430
2024-01-25

Synthetic platelets

#511
20240024341
2024-01-25

INHALATION FORMULATIONS OF 1`-CYANO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS

#512
20240024245
2024-01-25

MEDICINE PRODUCTION METHOD INCLUDING STEP OF FREEZE-DRYING WITH MIXED SOLVENT

#513
20240016885
2024-01-18

CYCLOSPORINE FORMULATIONS FOR USE IN THE PREVENTION OR TREATMENT OF PULMONARY CHRONIC GRAFT REJECTION

#514
20240016817
2024-01-18

Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders

#515
20240016762
2024-01-18

DUAL ANALGESIC/ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CB2 RECEPTOR AGONISTS, COMBINATIONS, AND METHODS OF USE THEREOF

#516
20240010675
2024-01-11

PREPARATION OF HIGHLY CONCENTRATED ALLERGENIC INTERMEDIATE

#517
20240009329
2024-01-11

FREEZE-DRIED MICROBUBBLES, THEIR USE, AND METHOD FOR PRODUCING THE SAME

#518
20240009228
2024-01-11

PEGYLATED RAPAMYCIN COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#519
20240009215
2024-01-11

COMPOUNDS AND COMPOSITIONS FOR TREATING SOLID TUMORS BY INTRATUMORAL ADMINISTRATION

#520
20240009175
2024-01-11

TETRAZOLE DERIVATIVES

#521
20240009133
2024-01-11

METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY CONDITIONS WITH CANNABIDIOL OR ITS DERIVATIVES/ANALOGS

#522
20240009132
2024-01-11

CANNABINOIDS IN THE TREATMENT OF AUTISM SPECTRUM DISORDER

#523
20240009131
2024-01-11

METHODS OF MAKING LIPID NANOPARTICLES

#524
20240009130
2024-01-11

RAPIDLY INFUSING COMPOSITIONS FOR ORAL MUCOSAL DELIVERY AND METHODS

#525
20240009129
2024-01-11

PACKAGING FOR RAPIDLY INFUSING COMPOSITION

#526
20240009123
2024-01-11

MULTI-SUPPLEMENT DELIVERY SYSTEM

#527
20240009119
2024-01-11

RAPIDLY INFUSING COMPOSITIONS WITH SUPPLEMENTS AND TREATMENT METHODS

#528
20240000719
2024-01-04

FORMULATIONS

#529
20240000711
2024-01-04

Lyophilization syringe

#530
20240000710
2024-01-04

Compositions and methods for nanoparticle lyophile forms

#531
20240000705
2024-01-04

USE OF SURFACTANT WITH HIGH MOLECULAR WEIGHT FISH GELATIN BASED DOSAGE FORMULATIONS TO IMPROVE FLOW CHARACTERISTICS

#532
20230416395
2023-12-28

ANTI-CD38 ANTIBODIES AND FORMULATIONS

#533
20230416276
2023-12-28

LYOPHILIZED PHARMACEUTICAL COMPOSITION AND USES OF A CRYSTALLIZED FORM OF LURBINECTEDIN

#534
20230414519
2023-12-28

RAPIDLY INFUSING COMPOSITIONS WITH METHOTREXATE AND TREATMENT METHODS

#535
20230414518
2023-12-28

RAPIDLY INFUSING CANNABINOID COMPOSITIONS, PROCESSES OF MANUFACTURE, AND METHODS OF USE

#536
20230414517
2023-12-28

FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION

#537
20230414516
2023-12-28

ENHANCED FORMULATION STABILIZATION AND IMPROVED LYOPHILIZATION PROCESSES

#538
20230414495
2023-12-28

PUNCTAL PLUGS CONTAINING MICELLE-ENCAPSULATED OPHTHALMIC PHARMACEUTICALS AND METHODS FOR MAKING THEREOF

#539
20230408195
2023-12-21

SYSTEM AND METHOD FOR MEASURING RAPID DECOMPRESSION ICE NUCLEATION IN LYOPHILIZATION

#540
20230405061
2023-12-21

COMBINATION PRODUCT FOR PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME

#541
20230404923
2023-12-21

USE OF A GROWTH FACTORS-ENRICHED DRY POWDER FOR RELIEVING INFLAMMATION OR INJURY

#542
20230399382
2023-12-14

Polyomavirus neutralizing antibodies

#543
20230399345
2023-12-14

CRYSTALLIZED FORM OF LURBINECTEDIN AND METHOD OF MAKING THE SAME

#544
20230399344
2023-12-14

A LYOPHILIZED PHARMACEUTICAL COMPOSITION

#545
20230398213
2023-12-14

PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HUMAN TSLP RECEPTOR ANTIBODY

#546
20230398096
2023-12-14

COMPOSITION COMPRISING TETRACYCLIC COMPOUND

#547
20230390342
2023-12-07

TREATMENT OF RADICULAR PAIN WITH CELL-FREE AMNIOTIC FLUID

#548
20230390317
2023-12-07

Remote loading of sparingly water-soluble drugs into lipid vesicles

#549
20230390234
2023-12-07

COMPOSITION INHIBITING MUSCLE LOSS OR PROMOTING MUSCLE FORMATION THROUGH SKIN-DERIVED EXOSOMES

#550
20230384603
2023-11-30

System and method directed to an eyeglasses-type wearable device

#551
20230381416
2023-11-30

MEDICAL DEVICE CONTAINING A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT, AND A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT.

#552
20230381311
2023-11-30

OPTIMIZED RATIOS OF AMINO ACIDS AND SUGARS AS AMORPHOUS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS

#553
20230381222
2023-11-30

LYOPHILIZED PHARMACEUTICAL COMPOSITIONS OF COPPER HISTIDINATE

#554
20230381186
2023-11-30

Compounds and methods for treating or preventing anterior segment ocular disorders and/or retinal degenerations

#555
20230374108
2023-11-23

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

#556
20230372480
2023-11-23

ANTI-IL-36R ANTIBODY FORMULATIONS

#557
20230372440
2023-11-23

IMPROVED PROCESS AND FORMULATION OF LIPID NANOPARTICLES

#558
20230372294
2023-11-23

LYOPHILIZED COMPOSITION COMPRISING (S)-ISOPROPYL 2-((S)-2-ACETAMIDO-3-(1H-INDOL-3-YL)PROPANAMIDO)-6-DIAZO-5-OXOHEXANOATE FOR SUBCUTANEOUS ADMINISTRATION AND THE USE THEREOF

#559
20230365692
2023-11-16

STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND HYALURONIDASE VARIANTS AND FRAGMENTS THEREOF AND METHODS OF USE THEREOF

#560
20230365669
2023-11-16

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA

#561
20230364213
2023-11-16

METHOD FOR LYOPHILIZING LIVE VACCINE STRAINS OF FRANCISELLA TULARENSIS

#562
20230364159
2023-11-16

MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE

#563
20230364154
2023-11-16

Methods and articles of manufacture for animal therapeutics

#564
20230364024
2023-11-16

Stabilized formulations of lipid nanoparticles

#565
20230364017
2023-11-16

BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION

#566
20230358472
2023-11-09

LYOPHILIZATION PROCESS AND A TEVERELIX-TFA LYOPHILIZATE OBTAINED THEREBY

#567
20230358470
2023-11-09

Target residual moisture content for lyophilized drug product

#568
20230357297
2023-11-09

MANUFACTURE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE (III)] AND COMPOSITIONS THEREOF

#569
20230357141
2023-11-09

TRISULFIDE COMPOUND

#570
20230355802
2023-11-09

Marine polysaccharide vector-based anthocyanin nanoparticles, and preparation method therefor and application thereof in targeted delivery

#571
20230355724
2023-11-09

Non-protein Clostridial toxin compositions

#572
20230355723
2023-11-09

Non-protein clostridial toxin compositions

#573
20230355709
2023-11-09

Lyophilized formulation

#574
20230355630
2023-11-09

SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS

#575
20230355544
2023-11-09

Pharmaceutical Composition Containing Elemene, Preparation Method Therefor, And Use Thereof

#576
20230348935
2023-11-02

VACCINE COMPOSITIONS FOR MUCOSAL IMMUNE RESPONSE

#577
20230348631
2023-11-02

PHARMACEUTICAL COMPOSITIONS OF CHEMOTHERAPEUTIC AGENTS BASED ON BETA-SUBSTITUTED BETA-AMINO ACID DERIVATIVES

#578
20230348596
2023-11-02

PHARMACEUTICAL FORMULATION

#579
20230346853
2023-11-02

Probiotic Lyophilizate Reactivation Composition for Improving Intestinal Survivability and Adhesion of Probiotics

#580
20230346839
2023-11-02

BLOOD PLASMA-CONTAINING COMPOSITIONS

#581
20230346708
2023-11-02

STABLE FORMULATIONS OF ANTI-CANCER PEPTIDES

#582
20230346704
2023-11-02

Pharmaceutical formulations

#583
20230346641
2023-11-02

LYOPHILISATE RETAINER, METHOD OF MANUFACTURING THEREOF AND PROCEDURE OF DRYING A SUBSTRATE

#584
20230338574
2023-10-26

ANTIBODY-NANOPARTICLE COMPLEXES AND METHODS FOR MAKING AND USING THE SAME

#585
20230338518
2023-10-26

Metal aluminum nano-adjuvant, vaccine composition and preparation method therefor and use thereof

#586
20230338497
2023-10-26

METHOD FOR PREPARING A VACCINE COMPOSITION FROM LYOPHILIZED ANTIGENS

#587
20230338491
2023-10-26

METHOD FOR SCREENING INDIVIDUAL TUMOR NEOANTIGEN PEPTIDE, AND VACCINE FORMULATION THEREOF

#588
20230338292
2023-10-26

Biodegradable polymer microsphere compositions for parenteral administration

#589
20230338284
2023-10-26

METHODS FOR THE TREATMENT OF LUNG TUMORS

#590
20230332154
2023-10-19

Amphiregulin gene-specific double-stranded oligonucleotide and composition for preventing and treating fibrosis-related diseases and respiratory diseases, comprising same

#591
20230331807
2023-10-19

IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS

#592
20230330234
2023-10-19

HYPERBRANCHED POLYESTER POLYOL DERIVATIVE AS DRUG SOLUBILIZER

#593
20230330205
2023-10-19

NOROVIRUS VACCINE

#594
20230330161
2023-10-19

MICROORGANISM STRAIN PEDIOCOCCUS ACIDILACTICI TAK 589 COCCOBEST AS AN ANTIMICROBIAL AND ANTIOXIDANT PROBIOTIC

#595
20230330160
2023-10-19

Pairing probiotics and prebiotics, methods for growth and use, separately and in combination

#596
20230330158
2023-10-19

INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE

#597
20230330026
2023-10-19

Large Fast Dispersing Tablet Prepared By Lyophilization

#598
20230324118
2023-10-12

Continuous throughput lyophilizer-powder filler within a sterile boundary

#599
20230322932
2023-10-12

Anti-BTN3A antibodies and their use in treating cancer or infectious disorders

#600
20230321283
2023-10-12

Near infrared fluorescent dyes, formulations and related methods